aluminoxamine has been researched along with Hemosiderosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andriani, M; Nordio, M; Saporiti, E | 1 |
| Becaus, I; Boelaert, JR; D'Haese, PC; De Broe, ME; Lamberts, LV; Verpooten, GA | 1 |
1 trial(s) available for aluminoxamine and Hemosiderosis
| Article | Year |
|---|---|
Pharmacokinetics of aluminoxamine and ferrioxamine and dose finding of desferrioxamine in haemodialysis patients.
Topics: Adult; Aged; Aluminum; Chelating Agents; Deferoxamine; Ferric Compounds; Hemosiderosis; Humans; Liver; Middle Aged; Mucormycosis; Organometallic Compounds; Renal Dialysis | 1992 |
1 other study(ies) available for aluminoxamine and Hemosiderosis
| Article | Year |
|---|---|
Estimation of statistical moments for desferrioxamine and its iron and aluminum chelates: contribution to optimisation of therapy in uremic patients.
Topics: Aluminum; Antidotes; Chelating Agents; Data Interpretation, Statistical; Deferoxamine; Drug Administration Schedule; Ferric Compounds; Hemosiderosis; Humans; Infusions, Intravenous; Iron; Kidney Failure, Chronic; Middle Aged; Organometallic Compounds; Renal Dialysis; Uremia | 1996 |